NCT00201448View on ClinicalTrials.gov

Evaluation of the Safety and Immune Responses of the Towne Strain of CMV in Seronegative Women

PHASE2/PHASE3TerminatedINTERVENTIONAL
Enrollment

82

Participants

Timeline

Start Date

June 30, 2007

Primary Completion Date

October 31, 2009

Study Completion Date

October 31, 2009

Conditions
Cytomegalovirus Infections
Interventions
BIOLOGICAL

Hepatitis A Vaccine

Single dose give IM

BIOLOGICAL

Towne CMV Vaccine

Single dose given subcutaneously

Trial Locations (1)

23298

Virginia Commonwealth University, Richmond

Sponsors
All Listed Sponsors
collaborator

CMV Research Foundation Inc

UNKNOWN

lead

Virginia Commonwealth University

OTHER